claim
Extremozymes and secondary metabolites derived from extremophiles offer advantages over conventional drugs, including thermostability for storage and delivery, novel structures that bypass existing resistance mechanisms, and high specificity that reduces off-target effects.

Authors

Sources

Referenced by nodes (1)